Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. ketamine, astrocytic inhibitor and pain
<p>Abstract</p> <p>Background</p> <p>Neuropathic pain is an intractable clinical problem. Intrathecal ketamine, a noncompetitive N--methyl-D-aspartate receptor (NMDAR) antagonist, is reported to be useful for treating neuropathic pain in clinic by inhibiting the activit...
Main Authors: | Mei Xiao-Peng, Wang Wei, Wang Wen, Zhu Chao, Chen Lei, Zhang Ting, Xu Li-Xian, Wu Sheng-Xi, Li Yun-Qing |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-09-01
|
Series: | Molecular Pain |
Online Access: | http://www.molecularpain.com/content/6/1/50 |
Similar Items
-
Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain
by: Wang Wen, et al.
Published: (2011-01-01) -
The Inhibition of Spinal Astrocytic JAK2-STAT3 Pathway Activation Correlates with the Analgesic Effects of Triptolide in the Rat Neuropathic Pain Model
by: Jun Tang, et al.
Published: (2012-01-01) -
Delta Opioid Receptor in Astrocytes Contributes to Neuropathic Cold Pain and Analgesic Tolerance in Female Mice
by: David Reiss, et al.
Published: (2021-09-01) -
The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
by: Sara Marinelli, et al.
Published: (2012-01-01) -
The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice.
by: Keisuke Shibata, et al.
Published: (2011-01-01)